Morphine Sulfate 20 mg/ml/Bupivacaine HCL 11 — Class II drug recall D-0744-2016
Terminated recall by Hartley Medical Center Pharmacy, Incorporated, reported 2016-03-16, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0744-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hartley Medical Center Pharmacy, Incorporated, Long Beach, CA, United States |
| Recall initiated | 2016-02-04 |
| Classified | 2016-03-04 |
| Reported by FDA | 2016-03-16 |
| Terminated | 2016-08-09 |
| Distributed | Nationwide (US) |
| Quantity | 1 syringes |
| Reason classes | sterility |
| Expiration dates | 2016-05-03 |
Product
Morphine Sulfate 20 mg/ml/Bupivacaine HCL 11.3 mg/ml, vol. 40 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0744-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.